1M6MYTD1A5AMAX
Caricamento quotazioni...
Previsioni
| Acquista |
5 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Bio-Path Holdings moves headquarters to Wyoming and creates Series S preferred shares
Bio-Path Holdings approved the move of its headquarters to Wyoming and filed an amendment to its charter to create a new class of Series S preferred shares consisting of 51 shares, each convertible into one common share and representing 1% of diluted voting power. The company also appointed Wendy M. Charles and Michael Hickey to a newly formed scientific advisory board; both received three-year contracts and were granted 100,000 stock options each with an exercise price of $0.06. The information comes from a filing with the SEC. » Altro su de.investing.com
Dati finanziari dell'azienda
| (EUR) | giugno 2026 | |
|---|---|---|
| Ricavi | 0 | - |
| Utile lordo | 0 | 100,00% |
| Utile netto | -2,31 Mln | 40,78% |
| EBITDA | -821,01K | 78,60% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 147,93K € |
Numero di azioni | 9,34 Mln |
Massimo/minimo a 52 settimane | 0,11 € - 0,00861 € |
| Dividendi | No |
Beta | -0,50 |
Rapporto P/E | -0,07 |
Rapporto PEG | 0,00 |
Rapporto P/B | -0,06 |
Rapporto P/S | 0,00 |
Profilo aziendale
| Nome | BIO-PATH HLDGS IN.DL-,001 Aktie |
| CEO | Vikram Paul Grover |
| Dipendenti | 1 |
Scopri gli asset
Gli azionisti di BIO-PATH HLDGS IN.DL-,001 Aktie investono anche nei seguenti asset
